Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

X1-FFR

K-Number: K251355 · 2025-10-17

Decision Date2025-10-17
Product CodeQHA
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

X1-FFR is the device name listed in this FDA 510(k) record. The listed applicant is Spectrawave, Inc.. It received FDA 510(k) clearance on 2025-10-17 under 510(k) number K251355. The device is classified under product code QHA. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the X1-FFR?

X1-FFR is a medical device that received FDA 510(k) clearance on 2025-10-17. The listed applicant is Spectrawave, Inc.. The 510(k) number is K251355.

When did X1-FFR receive FDA 510(k) clearance?

X1-FFR received FDA 510(k) clearance on 2025-10-17, under 510(k) number K251355.

Who is the listed applicant for X1-FFR?

The FDA 510(k) record lists Spectrawave, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for X1-FFR?

The FDA product code for X1-FFR is QHA.

Other records listing Spectrawave, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: QHA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.